+ |
MAP4K1 | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273899 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
PKA | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273898 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
PIM1 | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273895 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
PIM2 | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273896 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
MAP4K2 | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273900 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
PIM3 | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273897 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
NEK6 | up-regulates activity
phosphorylation
|
PSMD2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-273894 |
Ser361 |
ENNRFGGsGSQVDSA |
in vitro |
|
pmid |
sentence |
31843888 |
Seven of these kinases (PIM1/2/3, MAP4K1/2, PKA, and NEK6) directly and robustly phosphorylated recombinant GST-Rpn1 at S361 in vitro (Fig. 3D and SI Appendix, Fig. S3 A and B). |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
bortezomib | down-regulates activity
chemical inhibition
|
PSMD2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-259313 |
|
|
Homo sapiens |
Myeloma Cell |
pmid |
sentence |
21504411 |
Proteasome inhibition is a modern and surprisingly successful approach how to cancer treatment. Bortezomib (Velcade®) is a first-in-class proteasome inhibitor and has been approved for first-line treatment of multiple myeloma and second-line treatment of mantle cell lymphoma. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PSMD2 | form complex
binding
|
26S Proteasome |
0.887 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263344 |
|
|
Homo sapiens |
|
pmid |
sentence |
29636472 |
Here, we report near-atomic resolution cryo-EM structures of the activated human proteasome|The proteasome is composed of a 28-subunit barrel-shaped core particle (CP) and two 19- subunit regulatory particles (RP)5–8 capped at both sides of the CP|Human proteasomes were purified through affinity chromatography on a large scale from a stable HEK293 cell line |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
UBE3A | down-regulates quantity by destabilization
ubiquitination
|
PSMD2 |
0.28 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265133 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
28559284 |
Our experiments collectively suggest that UBE3A stimulates Wnt pathway activation by interacting with, ubiquitinating, and reducing the levels of multiple (PSMB1, PSMC2, PSMD2, and PSMD7) proteasome subunits. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |